Partner | Corporate and Commercial, Corporate Restructuring, Regulatory Practice
- T: +91 120 479 1000
- E: Write to me
education
- LL.B., D.D.U. Gorakhpur University ( Gold Medalist) (2005)
- B.Com.,D.D.U. Gorakhpur University (2002)
Atul Pandey is a Partner in the Corporate team in the Delhi NCR office. He has been advising on corporate, M&A and commercial issues, regulatory matters including under the Foreign Exchange Management Act, 1999, FDI Policy, overseas investment regime and obtaining approvals, mergers & acquisitions (domestic and cross-border), domestic and cross-border joint ventures, capital markets, private equity investment, labour & employment and trade laws, direct & indirect tax, dispute resolution, banking & finance, and other areas of corporate law practice.
Professional Affiliations
- Bar Council of Delhi
Representative Matters
Atul Pandey has represented and advised the following clients
GlaxoSmithKline Plc (GSK)
Advised and obtained FIPB approval in relation to a major three-part global transaction between GSK and Novartis AG (Novartis), pursuant to which GSK is forming a consumer health joint venture with Novartis, while at the same time buying Novartis vaccines business and divesting its cancer drugs portfolio to Novartis. The three inter-conditional deals are worth over USD 20 billion.
MacRitchie Pte Ltd (Temasek entity)
Advised on the transaction and obtained FIPB approval in respect of foreign direct investment and proposed issue and allotment of compulsory convertible preference shares representing 49.99% of the fully diluted post issue share capital of MakeSense Technologies Limited, on a private placement basis to MacRitchie Investments Pte Ltd, a wholly owned indirect subsidiary of Temasek Holdings (Private) Limited, Singapore.
Mitsui & Co. (Asia Pacific) Pte Ltd
Advised on the transaction and obtained DIPP clarification/approval in respect of proposed investment in Keimed Private Limited, an Indian company engaged exclusively in the business of wholesale trading of pharmaceutical and medical goods, and with specific reference to whether wholesale trading of pharmaceutical products would fall within the automatic route or would it require approval from the FIPB.
Jindal Steel & Power
Advised on the transaction and obtained regulatory approval from RBI for undertaking financial commitment by Jindal Steel & Power Limited by way of issue of bank guarantee in form of ‘Stand by Letter of Credit’ on behalf of JSPL’s overseas wholly owned subsidiary, Jindal Steel & Power (Mauritius) Limited and provision of cash collateral.
BYD Group
Advised on proposed joint venture with an Indian conglomerate for manufacture and sale of automobiles
Grupo Antolin
Advised on sale of three Indian subsidiaries for an enterprise value of EUR 159 million
Bollore Group
Advised on (i) select India aspects in relation to sale of Bollore Africa Logistics to MSC group; (ii) select India aspects in relation to sale of Bollore Logistics to CMA-CGM group; and (iii) investment in Dakshin Bharat Gateway Terminal, a container terminal operator in Tamil Nadu
Delachaux S.A.
Advised on the Indian law aspects of the sale of its shares in Frauscher Sensor Technology Grou.p GmbH (Austria) to Wabtec Corporation
Dixon Technologies
Advised on (i) joint ventures with Bharti Group, Longcheer Group and HKC Groups; and (ii) acquisition of Padget Electronics
Hindustan Times Media
Advised on respect of acquisition of Radio One through a composite scheme of arrangement
SWC Global Fund
Advised on investments in (i) Country Delight as part of its Series D round; (ii) Mudrex as part of its Series A round; (iii) Webengage as part of its Series B round; (iv) Sinecycle Technologies as part of its seed financing; and (v) MeetRecords as part of its Pre-Series A round
Delachaux S.A.
Advised on the Indian law aspects of the sale of its shares in Frauscher Sensor Technology Grou.p GmbH (Austria) to Wabtec Corporation
Publications
Ergo Newsflash
Ergo Update
Article
Article
Ergo Newsflash
Ergo Update
News and Events
Atul Pandey has featured in the following news and webinars
